Trial Profile
Metformin +/- sitagliptin in patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Feb 2013
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 18 Feb 2013 New trial record